BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6174376)

  • 1. Could aspiration of the Graafian follicle cause luteal phase deficiency?
    Feichtinger W; Kemeter P; Szalay S; Beck A; Janisch H
    Fertil Steril; 1982 Feb; 37(2):205-8. PubMed ID: 6174376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal phase following oocyte aspiration, in vitro fertilization, and embryo transfer in clomid/HCG-stimulated cycles.
    Trotnow S; Becker H; Kniewald T; Al-Hasani S; Mulz D
    Arch Gynecol; 1982; 231(3):171-6. PubMed ID: 7125698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin in sera during the luteal phase of in-vitro fertilization cycles.
    Eddie LW; Martinez F; Healy DL; Sutton B; Bell RJ; Tregear GW
    Br J Obstet Gynaecol; 1990 Mar; 97(3):215-20. PubMed ID: 1692232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two years' experience of ultrasound-directed oocyte retrieval.
    Riddle AF; Sharma V; Mason BA; Ford NT; Pampiglione JS; Parsons J; Campbell S
    Fertil Steril; 1987 Sep; 48(3):454-8. PubMed ID: 2442036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and hormonal treatment of the luteal phase of in vitro fertilization cycles.
    Yovich JL; Stanger JD; Yovich JM; Tuvik AI
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):125-30. PubMed ID: 6208891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
    Huang KE; Muechler EK; Schwarz KR; Goggin M; Graham MC
    Fertil Steril; 1986 Nov; 46(5):903-6. PubMed ID: 3096786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilization.
    Yovich JL; Stanger JD; Yovich JM; Tuvik AI; Turner SR
    Br J Obstet Gynaecol; 1985 Apr; 92(4):374-84. PubMed ID: 2580551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.
    Yamashita T; Okamoto S; Thomas A; MacLachlan V; Healy DL
    Fertil Steril; 1989 Feb; 51(2):304-9. PubMed ID: 2463940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Hum Reprod; 1999 Nov; 14(11):2777-82. PubMed ID: 10548621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-specific beta 1-glycoprotein (SP1) after in vitro fertilization and embryo transfer.
    Marty F; Bersinger N; Birkhäuser M; Balerna M; Campana A; Eppenberger U
    Arch Gynecol; 1987; 240(3):185-90. PubMed ID: 2439029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The luteal phase after hyperstimulation for in vitro fertilization.
    Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB
    Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficiency of human reproduction after in vitro fertilization and embryo transfer.
    Liu HC; Jones HW; Rosenwaks Z
    Fertil Steril; 1988 Apr; 49(4):649-53. PubMed ID: 3350159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilization and embryo transfer in the rhesus monkey.
    Wolf DP; Vandevoort CA; Meyer-Haas GR; Zelinski-Wooten MB; Hess DL; Baughman WL; Stouffer RL
    Biol Reprod; 1989 Aug; 41(2):335-46. PubMed ID: 2508776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clomid induced superovulation on human follicular and luteal function for extracorporeal fertilization and embryo transfer.
    Kerin JF; Warnes GM; Quinn P; Jeffrey R; Godfrey B; Broom TJ; McEvoy M; Kirby C; Johnson M; Cox LW
    Clin Reprod Fertil; 1983 Jun; 2(2):129-42. PubMed ID: 6671191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
    Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
    J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.